menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free
ReachMD Faculty

Public Profile

Geoffrey Ginsburg, MD, PhD
Geoffrey Ginsburg, MD, PhD

    Dr. Geoffrey S. Ginsburg is the founding director of the Center for Genomic Medicine in the Duke Institute for Genome Sciences & Policy, which focuses on oncology, infectious diseases, cardiovascular disease, and metabolic disorders. He is also professor of medicine and of pathology at Duke University Medical Center. He received his medical degree and doctoral degree in biophysics from Boston University and completed an internal medicine residency at Beth Israel Hospital in Boston. Subsequently, he pursued postdoctoral training in clinical cardiovascular medicine at Beth Israel Hospital and in molecular biology at Children's Hospital as a Bugher Foundation Fellow of the American Heart Association. In 1990, he joined the faculty of Harvard Medical School, where he was director of preventive cardiology and led a laboratory in applied genetics of cardiovascular disease. In 1997, he joined Millennium Pharmaceuticals, Inc., as senior program director for cardiovascular diseases. In 2000, he was appointed vice president of molecular and personalized medicine at Millennium, where he was responsible for developing pharmacogenomic strategies for therapeutics, as well as biomarkers for disease and their implementation in the drug development process. He assumed his current position in the Duke Institute for Genome Sciences & Policy in September 2004, and, in 2006, he was also appointed as co-director of the Duke Translational Medicine Institute. At Duke, he has pioneered translational genomics and has initiated the first genomic-guided clinical trials, as well as developed novel practice models for deploying genomic tools in health care systems.

    Dr. Ginsburg has received a number of awards for his research accomplishments, including the Innovator in Medicine Award from Millennium in 2004 and the Basic Research Achievement Award in Cardiovascular Medicine from Duke in 2005. He is a founding member of the Personalized Medicine Coalition, a senior consulting editor for the Journal of the American College of Cardiology, and an associate editor for Genomic Medicine. He has been an international expert panel member for Genome Canada and is currently a member of the following groups: the Board of External Experts for the National Heart Lung and Blood Institute, the Secretary of Veterans Affairs Advisory Council on Genomic Medicine, the Institute of Medicine's Roundtable on Genome Based Research to Human Health. He was recently appointed to National Advisory Council for Human Genome Research and is currently a nominee for the Food and Drug Administration's Advisory Committee for Clinical Pharmacology.

    Dr. Ginsburg's research interests are in the development of novel paradigms for developing and translating genomic information into medical practice and the integration of personalized medicine into health care.

    Schedule28 Mar 2024